Drug Database
Back to search

Netherlands· NL-e962501b43a6

Maapliv oplossing voor infusie

A aminosäuren product containing alanine, (l-) + arginine, (l-) + asparaginezuur, (l-) + cysteine (l-)hydrochloride 1-water (e 920), registered in Netherlands by Recordati Rare Diseases. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMaapliv oplossing voor infusieATCB05BA01REGISTER NO.NL-e962501b43a6PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alanine, (l-) + arginine, (l-) + asparaginezuur, (l-) + cysteine (l-)hydrochloride 1-water (e 920)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aminosäuren is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA01 (aminosäuren), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search aminosäuren products by name

Aminosäuren · ATC B05BA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ALANINE, (L-) + ARGININE, (L-) + ASPARAGINEZUUR, (L-) + CYSTEINE (L-)HYDROCHLORIDE 1-WATER (E 920)
Manufacturer
Recordati Rare Diseases
Country
Netherlands (NL)
ATC code
B05BA01
ATC class
Aminosäuren
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/25/1955

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for aminosäuren.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aminosäuren against other medicinesHow interaction checks work

Aminosäuren · interactions on record

4 records

  • 4 moderate

Most severe, free to view

  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • MetamfetamineN06BA03moderate
  • LisdexamfetamineN06BA12moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B05BA01

Aminosäuren, as other registers publish it.

All aminosäuren products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/02b5b474-6f37-47f4-b823-f7b6a50e5a65
GET /v1/drugs/02b5b474-6f37-47f4-b823-f7b6a50e5a65?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/maapliv-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Amino Acids",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp132281",
  "excipients": [
    "AZIJNZUUR (E 260)",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "ALANINE, (L-)",
    "ARGININE, (L-)",
    "ASPARAGINEZUUR, (L-)",
    "CYSTEINE (L-)HYDROCHLORIDE 1-WATER (E 920)",
    "FENYLALANINE, (L-)",
    "GLUTAMINEZUUR (L-) (+) (E 620)",
    "GLYCINE (E 640)",
    "HISTIDINE, (L-)",
    "LYSINE (L-) 1-WATER",
    "METHIONINE, (L-)",
    "PROLINE, (L-)",
    "SERINE, (L-)",
    "TAURINE",
    "THREONINE, (L-)",
    "TRYPTOFAAN, (L-)",
    "TYROSINE, (L-)"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/07/28",
  "procedure_number": "EMEA/H/C/005557",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/1955",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about aminosäuren.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console